Raptor Pharmaceuticals Corp. (RPTP.OB) is “One to Watch”
Source: http://Blog.QualityStocks.net/?p=14629Posted on Monday, March 9th, 2009 | In Small & Micro Cap
Raptor has focused its efforts on speeding the delivery of new treatment options to patients by working to improve existing therapeutics through the application of highly specialized drug targeting platforms and formulation expertise. The company is primarily dedicated to underserved patient populations where they can have the greatest potential impact.
Raptor is developing a balanced, robust pipeline of drug candidates. The company’s current product portfolio includes candidates from their proprietary drug targeting platforms and in-licensed and acquired product candidates. Raptor’s current pipeline includes 5 clinical development programs plus 3 preclinical programs, all of which are based on a strong IP position.
The company is developing drug-targeting platforms based on the proprietary use of the human protein called receptor-associated protein (RAP) and the mesoderm development protein (Mesd). They believe that these proteins may have therapeutic applications in cancer, infectious diseases and neurodegenerative diseases, among others.
Raptor’s growth strategy is based on leveraging the company’s in-house research and development capabilities through partnerships, acquisitions and collaborations. This approach has already proven effective for the company, leading the way to a balanced portfolio of product candidates with the potential to reach a broad array of underserved patient populations.
Let us hear your thoughts: Raptor Pharmaceuticals Corp. Message Board
Last 5 posts by QualityStocks
- Omnicity Corp. (OMCY.OB) Announces Addition of New Board Member - November 20th, 2009
- Muscle Flex, Inc. (MFLI.PK) Announces Release Time for the BUDDY Tablet Caddy Two-Minute Commercial and Landing Page - November 20th, 2009
- Artfest International, Inc. (ARTS.OB) Announces Revenue Profit Jumps - November 20th, 2009
- Omnicity Corp.’s (OMCY.OB) Recently-Issued Corporate Update - November 20th, 2009
- Soligenix Inc. (SNGX.OB) Taking Steps to Meet Challenges of Vaccine Technology and Biological Warfare - November 20th, 2009
cancer, Infectious Diseases, Message Board, neurodegenerative diseases, Raptor Pharmaceuticals Corp.;, Small & Micro Cap, Therapeutic Applications
 About QualityStocks (http://QualityStocks.net)
Our name, QualityStocks, emphasizes our commitment to connect subscribers with companies that have huge potential to succeed in the short and long-term future. We believe strong management and vision for the future are crucial for any company to be successful. Timing is everything and we help investors succeed by providing an objective, broad-based view of the SmallCap markets on a daily basis. Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net |
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.